RB gene family: Genome-wide ChIP approaches could open undiscovered roads

Journal of Cellular Biochemistry

Volumn 109, Issue 5, 2010, Pages 839-843

  Rizzolio, Flavio ^a,b   Esposito, Luca ^c   Muresu, Debora ^a   Fratamico, Robert ^a   Jaraha, Ranna ^a   Caprioli, Gianluca Vosa ^a   Giordano, Antonio ^a,b  

^a Temple University   (United States)

^b UNIVERSITY OF SIENA   (Italy)

^c CROM Center of Oncology Research Mercogliano   (Italy)

Author keywords

Cell cycle; ChIP genome wide; RBF

Indexed keywords

CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; DNA; HISTONE; PROTEIN INTERACTING WITH PROTEIN KINASE C; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F;

CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; DNA REPLICATION; DNA SEQUENCE; EPIGENETICS; GENE REPRESSION; GENETIC TRANSCRIPTION; GENOMICS; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; TRANSCRIPTION REGULATION;

ANIMALS; CELL CYCLE; CHROMATIN IMMUNOPRECIPITATION; GENOME; HUMANS; MULTIGENE FAMILY; RETINOBLASTOMA PROTEIN;

EID: 77950401420     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22448     Document Type: Review

References (53)

1. Attwooll C, Lazzerini Denchi E, Helin K. 2004. The E2F family: Specific functions and overlapping interests. EMBO J 23:4709-4716.
2. Balciunaite E, Spektor A, Lents NH, Cam H, Te Riele H, Scime A, Rudnicki MA, Young R, Dynlacht BD. 2005. Pocket protein complexes are recruited to distinct targets in quiescent and proliferating cells. Mol Cell Biol 25:8166-8178.
3. Cam H, Balciunaite E, Blais A, Spektor A, Scarpulla RC, Young R, Kluger Y, Dynlacht BD. 2004. A common set of gene regulatory networks links metabolism and growth inhibition. Mol Cell 16:399-411.
4. Carroll JS, Liu XS, Brodsky AS, Li W, Meyer CA, Szary AJ, Eeckhoute J, Shao W, Hestermann EV, Geistlinger TR, Fox EA, Silver PA, Brown M. 2005. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122:33-43.
5. Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, Eeckhoute J, Brodsky AS, Keeton EK, Fertuck KC, Hall GF, Wang Q, Bekiranov S, Sementchenko V, Fox EA, Silver PA, Gingeras TR, Liu XS, Brown M. 2006. Genome-wide analysis of estrogen receptor binding sites. Nat Genet 38:1289-1297.
6. Cawley S, Bekiranov S, Ng HH, Kapranov P, Sekinger EA, Kampa D, Piccolboni A, Sementchenko V, Cheng J, Williams AJ, Wheeler R, Wong B, Drenkow J, Yamanaka M, Patel S, Brubaker S, Tammana H, Helt G, Struhl K, Gingeras TR. 2004. Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell 116:499-509.
7. Classon M, Dyson N. 2001. p107 and p130: Versatile proteins with interesting pockets. Exp Cell Res 264:135-147.
8. Classon M, Harlow E. 2002. The retinoblastoma tumour suppressor in development and cancer. Nat Rev Cancer 2:910-917.
9. Cobrinik D. 2005. Pocket proteins and cell cycle control. Oncogene 24:2796-2809.
10. Dannenberg JH, Schuijff L, Dekker M, van der Valk M, te Riele H. 2004. Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130. Genes Dev 18:2952-2962.
11. DeGregori J, Johnson DG. 2006. Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis. Curr Mol Med 6:739-748.
12. DeGregori J, Leone G, Miron A, Jakoi L, Nevins JR. 1997. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc Natl Acad Sci USA 94:7245-7250.
13. Dunn JM, Phillips RA, Becker AJ, Gallie BL. 1988. Identification of germline and somatic mutations affecting the retinoblastoma gene. Science 241:1797-1800.
14. Ewen ME, Xing YG, Lawrence JB, Livingston DM. 1991. Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell 66:1155-1164.
15. Farnham PJ. 2009. Insights from genomic profiling of transcription factors. Nat Rev Genet 10:605-616.
16. Flemington EK, Speck SH, Kaelin WG, Jr. 1993. E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc Natl Acad Sci USA 90:6914-6918.
17. Goodrich DW, Wang NP, Qian YW, Lee EY, Lee WH. 1991. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 67:293-302.
18. Hannon GJ, Demetrick D, Beach D. 1993. Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes Dev 7:2378-2391.
19. Helin K, Ed H. 1993. The retinoblastoma protein as a transcriptional repressor. Trends Cell Biol 3:43-46.
20. Howard CM, Claudio PP, Gallia GL, Gordon J, Giordano GG, Hauck WW, Khalili K, Giordano A. 1998. Retinoblastoma-related protein pRb2/p130 and suppression of tumor growth in vivo. J Natl Cancer Inst 90:1451-1460.
21. Iaquinta PJ, Lees JA. 2007. Life and death decisions by the E2F transcription factors. Curr Opin Cell Biol 19:649-657.
22. Ichimura K, Hanafusa H, Takimoto H, Ohgama Y, Akagi T, Shimizu K. 2000. Structure of the human retinoblastoma-related p107 gene and its intragenic deletion in a B-cell lymphoma cell line. Gene 251:37-43.
23. Knudson AG, Jr. 1971. Mutation and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820-823.
24. Kouzarides T. 2007. Chromatin modifications and their function. Cell 128:693-705.
25. Laganiere J, Deblois G, Giguere V. 2005. Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells. Mol Endocrinol 19:1584-1592.
26. Lee EY, Cam H, Ziebold U, Rayman JB, Lees JA, Dynlacht BD. 2002. E2F4 loss suppresses tumorigenesis in Rb mutant mice. Cancer Cell 2:463-472.
27. Li Y, Graham C, Lacy S, Duncan AM, Whyte P. 1993. The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev 7:2366-2377.
28. Litovchick L, Sadasivam S, Florens L, Zhu X, Swanson SK, Velmurugan S, Chen R, Washburn MP, Liu XS, DeCaprio JA. 2007. Evolutionarily conserved multisubunit RBL2/p130 and E2F4 protein complex represses human cell cycle-dependent genes in quiescence. Mol Cell 26:539-551.
29. Liu N, Lucibello FC, Zwicker J, Engeland K, Muller R. 1996. Cell cycle-regulated repression of B-myb transcription: Cooperation of an E2F site with a contiguous corepressor element. Nucleic Acids Res 24:2905-2910.
30. MacLellan WR, Garcia A, Oh H, Frenkel P, Jordan MC, Roos KP, Schneider MD. 2005. Overlapping roles of pocket proteins in the myocardium are unmasked by germ line deletion of p130 plus heart-specific deletion of Rb. Mol Cell Biol 25:2486-2497.
31. Marino S, Vooijs M, van Der Gulden H, Jonkers J, Berns A. 2000. Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. Genes Dev 14:994-1004.
32. Markey MP, Angus SP, Strobeck MW, Williams SL, Gunawardena RW, Aronow BJ, Knudsen ES. 2002. Unbiased analysis of RB-mediated transcriptional repression identifies novel targets and distinctions from E2F action. Cancer Res 62:6587-6597.
33. Mayol X, Grana X, Baldi A, Sang N, Hu Q, Giordano A. 1993. Cloning of a new member of the retinoblastoma gene family (pRb2) which binds to the E1A transforming domain. Oncogene 8:2561-2566.
34. Misteli T. 2007. Beyond the sequence: Cellular organization of genome function. Cell 128:787-800.
35. Morris EJ, Dyson NJ. 2001. Retinoblastoma protein partners. Adv Cancer Res 82:1-54.
36. Mulligan G, Jacks T. 1998. The retinoblastoma gene family: Cousins with overlapping interests. Trends Genet 14:223-229.
37. Nevins JR. 1998. Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ 9:585-593.
38. Paggi MG, Giordano A. 2001. Who is the boss in the retinoblastoma family? The point of view of Rb2/p130, the little brother. Cancer Res 61:4651-4654.
39. Paggi MG, Baldi A, Bonetto F, Giordano A. 1996. Retinoblastoma protein family in cell cycle and cancer: A review. J Cell Biochem 62:418-430.
40. Robanus-Maandag E, Dekker M, van der Valk M, Carrozza ML, Jeanny JC, Dannenberg JH, Berns A, te Riele H. 1998. p107 is a suppressor of retinoblastoma development in pRb-deficient mice. Genes Dev 12:1599-1609.
41. Robinson GW, Wagner KU, Hennighausen L. 2001. Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene. Oncogene 20:7115-7119.
42. Ruiz S, Santos M, Segrelles C, Leis H, Jorcano JL, Berns A, Paramio JM, Vooijs M. 2004. Unique and overlapping functions of pRb and p107 in the control of proliferation and differentiation in epidermis. Development 131:2737-2748.
43. Sellers WR, Rodgers JW, Kaelin WG, Jr. 1995. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites. Proc Natl Acad Sci USA 92:11544-11548.
44. Simin K, Wu H, Lu L, Pinkel D, Albertson D, Cardiff RD, Van Dyke T. 2004. pRb inactivation in mammary cells reveals common mechanisms for tumor initiation and progression in divergent epithelia. PLoS Biol 2:E22.
45. Stengel KR, Thangavel C, Solomon DA, Angus SP, Zheng Y, Knudsen ES. 2009. Retinoblastoma/p107/p130 pocket proteins: Protein dynamics and interactions with target gene promoters. J Biol Chem 284:19265-19271.
46. Stevaux O, Dyson NJ. 2002. A revised picture of the E2F transcriptional network and RB function. Curr Opin Cell Biol 14:684-691.
47. Takahashi Y, Rayman JB, Dynlacht BD. 2000. Analysis of promoter binding by the E2F and pRB families in vivo: Distinct E2F proteins mediate activation and repression. Genes Dev 14:804-816.
48. Vandromme M, Chailleux C, Escaffit F, Trouche D. 2008. Binding of the retinoblastoma protein is not the determinant for stable repression of some E2F-regulated promoters in muscle cells. Mol Cancer Res 6:418-425.
49. Weintraub SJ, Prater CA, Dean DC. 1992. Retinoblastoma protein switches the E2F site from positive to negative element. Nature 358:259-261.
50. Wells J, Yan PS, Cechvala M, Huang T, Farnham PJ. 2003. Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sites during S phase. Oncogene 22:1445-1460.
51. Wikenheiser-Brokamp KA. 2006. Retinoblastoma family proteins: Insights gained through genetic manipulation of mice. Cell Mol Life Sci 63:767-780.
52. Xiao A, Wu H, Pandolfi PP, Louis DN, Van Dyke T. 2002. Astrocyte inactivation of the pRb pathway predisposes mice to malignant astrocytoma development that is accelerated by PTEN mutation. Cancer Cell 1:157-168.
53. Zhu L, van den Heuvel S, Helin K, Fattaey A, Ewen M, Livingston D, Dyson N, Harlow E. 1993. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev 7:1111-1125.